{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:24:56Z","timestamp":1773865496437,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nefroe.2026.501468","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:55:06Z","timestamp":1773838506000},"page":"501468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretation of glycaemic variability in type 2 diabetes mellitus patients on maintenance haemodialysis using continuous glucose monitoring"],"prefix":"10.1016","volume":"46","author":[{"given":"Asokan","family":"Arunkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6886-9015","authenticated-orcid":false,"given":"Varadharajan","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendran","family":"Rajasekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew Gerry","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2026.501468_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1797.2011.01517.x","article-title":"Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring","volume":"17","author":"Vos","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.nefroe.2026.501468_bib0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1744-9987.2007.00492.x","article-title":"Evaluation of the haemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: comparison between the haemodialysis and non-haemodialysis days","volume":"11","author":"Abe","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.nefroe.2026.501468_bib0135","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00592-021-01699-6","article-title":"Continuous glucose monitoring in patients with type 2 diabetes on haemodialysis","volume":"58","author":"Gallieni","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.nefroe.2026.501468_bib0140","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/dc21-0269","article-title":"Haemodialysis-related glycaemic disarray proven by continuous glucose monitoring; glycaemic markers and hypoglycaemia","volume":"44","author":"Hayashi","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nefroe.2026.501468_bib0145","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15139","article-title":"A randomized trial of continuous glucose monitoring to improve post-transplant glycaemic control","volume":"37","author":"Jandovitz","year":"2023","journal-title":"Clin Transplant"},{"issue":"5S","key":"10.1016\/j.nefroe.2026.501468_bib0150","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"issue":"Suppl. 1","key":"10.1016\/j.nefroe.2026.501468_bib0155","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.nefroe.2026.501468_bib0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13098-021-00722-8","article-title":"Use of continuous glucose monitoring system in patients with type 2 mellitus diabetic during haemodialysis treatment","volume":"13","author":"Hissa","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.nefroe.2026.501468_bib0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40620-023-01802-w","article-title":"Continuous glucose monitoring in people with diabetes and end-stage renaly disease-review of association studies and Evidence-Based discussion","volume":"37","author":"Jakubowska","year":"2024","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefroe.2026.501468_bib0170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/dia.2010.0052","article-title":"Inter-day glycaemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on haemodialysis","volume":"12","author":"Mirani","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.nefroe.2026.501468_bib0175","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/dia.2010.0067","article-title":"Analysis of haemodialysis-associated hypoglycaemia in patients with type 2 diabetes using a continuous glucose monitoring system","volume":"12","author":"Jung","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.nefroe.2026.501468_bib0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jdiacomp.2014.12.015","article-title":"Blood glucose fluctuations in haemodialysis patients with end stage diabetic nephropathy","volume":"29","author":"Jin","year":"2015","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.nefroe.2026.501468_bib0185","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","article-title":"Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study","volume":"107","author":"Joubert","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.nefroe.2026.501468_bib0190","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/dc08-1688","article-title":"Assessing glycaemic control in maintenance haemodialysis patients with type 2 diabetes","volume":"32","author":"Kazempour-Ardebili","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nefroe.2026.501468_bib0195","doi-asserted-by":"crossref","first-page":"848","DOI":"10.4103\/ijem.IJEM_520_18","article-title":"Flash glucose monitoring in subjects with diabetes on haemodialysis: a pilot study","volume":"22","author":"Javherani","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.nefroe.2026.501468_bib0200","article-title":"Flash glucose monitoring to assess glycaemic control and variability in haemodialysis patients: the GIOTTO study","volume":"8","author":"Mambelli","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.nefroe.2026.501468_bib0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.14341\/DM12990","article-title":"Optimization of glycaemic control with continuous glucose monitoring in a patient with type 1 diabetes mellitus undergoing maintenance haemodialysis","volume":"26","author":"Markova","year":"2023","journal-title":"Diabetes Mellit"},{"key":"10.1016\/j.nefroe.2026.501468_bib0210","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nefroe.2026.501468_bib0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/hdi.13073","volume":"27","author":"Bomholt","year":"2023","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nefroe.2026.501468_bib0220","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ekir.2023.01.040","article-title":"Narrative review of glycaemic management in people with diabetes on peritoneal dialysis","volume":"8","author":"Wijewickrama","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.nefroe.2026.501468_bib0225","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/ndt\/gfp181","article-title":"Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system","volume":"24","author":"Riveline","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2026.501468_bib0230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12882-024-03763-z","article-title":"Efficacy of continuous glucose monitoring in people living with diabetes and end stage renal disease on dialysis: a systematic review","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2026.501468_bib0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/11630900-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of linagliptin","volume":"51","author":"Graefe-Mody","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nefroe.2026.501468_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.peptides.2013.01.014","article-title":"Glucagon-like peptides 1 and 2 in health and disease: a review","volume":"44","author":"Marathe","year":"2013","journal-title":"Peptides"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:55:51Z","timestamp":1773838551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251426000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2013251426000519"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501468","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpretation of glycaemic variability in type 2 diabetes mellitus patients on maintenance haemodialysis using continuous glucose monitoring","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}],"article-number":"501468"}}